{"id":"W2766527970","doi":"10.1016/j.jcjd.2017.08.019","title":"Responder Analysis of Subjects Achieving HbA1c ≥1% and Weight Loss ≥5% Across SUSTAIN 1–5 Clinical Trials","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Semaglutide; Medicine; Weight loss; Exenatide; Sitagliptin; Placebo; Hypoglycemia; Clinical endpoint; Internal medicine; Type 2 diabetes; Insulin glargine; Clinical trial; Dulaglutide; Diabetes mellitus; Pharmacology; Gastroenterology; Insulin; Obesity; Endocrinology; Liraglutide","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0247408,0.001249856,0.005453285,0.001535155,0.0007209755,0.001498112,0.001106977,0.001841186,0.009969041],"category_scores_gemma":[0.02927921,0.0005955186,0.007755313,0.001128373,0.0008634372,0.002104043,0.001544185,0.002162649,0.0007382407],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008193377,"about_ca_system_score_gemma":0.001183192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008650104,"about_ca_topic_score_gemma":0.001444543,"domain_scores_codex":[0.9814724,0.01062391,0.002476291,0.002401071,0.001852161,0.001174253],"domain_scores_gemma":[0.9797069,0.01056867,0.003781687,0.003817105,0.001386271,0.0007394058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8287741,0.001641221,0.05557009,0.002489098,0.05735644,0.0002616733,0.0004548864,0.0009642613,0.006062032,0.0005999068,0.004742966,0.04108331],"study_design_scores_gemma":[0.149386,0.1312051,0.6185625,0.0006706442,0.06823011,0.0007098139,0.0009351248,0.004561369,0.004881782,0.00287599,0.01774431,0.0002370912],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9649134,0.01013221,0.005182626,0.0009328081,0.0005233822,0.005245097,0.00768187,0.0003851519,0.005003472],"genre_scores_gemma":[0.9851152,0.0005969303,0.002263319,0.001327366,0.0002487892,0.003667998,0.003703932,0.00007841643,0.002997977],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0247408,"threshold_uncertainty_score":0.1308434,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06972482064087465,"score_gpt":0.3983941661836068,"score_spread":0.3286693455427322,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}